NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 03:44 PM
29/01/2026 20:44
NASDAQ TRADE HALT QNCX.O VOLATILITY TRADING PAUSE AT 03:44 PM
Recent news on IRulya Therapeutics
See all newsBrief: Quince Therapeutics - Changes Name To Irulya Therapeutics
Brief: Quince Therapeutics - Appoints Brigette Roberts As CEO Effective October 8, 2026
Quince Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Quince Therapeutics Reports Second Quarter 2026 Financial Results And Corporate Update
Quince Therapeutics Q2 net loss widens on acquisition charges